0.5 mg Other Ingredients: Glycerin, water, highly purified phospholipids, ethanol, tocofersolan, citrus essential oils Other Ingredients: Glycerin, water, highly purified phospholipids, ethanol, tocofersolan, citrus essential oils If pregnant or breast feeding, consult your healthcare practitioner before use
Jochems, A.M
Cagrilintide supplied for research purposes is manufactured as a high-purity, LPS-free peptide and is endotoxin-free , ensuring suitability for sensitive laboratory applications

less Figures (0) & Videos (0) Experimental Specifications Techniques Reagents Other Keywords Techniques Reagents Other Keywords Citations (116) Discover related articles Recombinant Expression and Purification of Animal Intracellular L-Type Lectins 2020, Springer Protocols Recombinant Expression and Purification of Animal Intracellular L-Type Lectins 2020, Springer Protocols Glycosyltransferase-Coupled Assays for 4-Epimerase WbpP from Pseudomonas aeruginosa 2019, Springer Protocols Glycosyltransferase-Coupled Assays for 4-Epimerase WbpP from Pseudomonas aeruginosa 2019, Springer Protocols Recombinant Expression and Purification of Animal Intracellular L-Type Lectins 2020, Springer Protocols Recombinant Expression and Purification of Animal Intracellular L-Type Lectins 2020, Springer Protocols Glycosyltransferase-Coupled Assays for 4-Epimerase WbpP from Pseudomonas aeruginosa 2019, Springer Protocols Glycosyltransferase-Coupled Assays for 4-Epimerase WbpP from Pseudomonas aeruginosa 2019, Springer Protocols Recombinant Reconstitution and Purification of the IFT-B Core Complex from Chlamydomonas reinhardtii 2016, Springer Protocols Recombinant Reconstitution and Purification of the IFT-B Core Complex from Chlamydomonas reinhardtii 2016, Springer Protocols FRET-Based In Vitro Assays for the Analysis of SUMO Protease Activities 2009, Springer Protocols FRET-Based In Vitro Assays for the Analysis of SUMO Protease Activities 2009, Springer Protocols In Vitro CFTR Folding Assays 2002, Springer Protocols In Vitro CFTR Folding Assays 2002, Springer Protocols References Smith, D

CagriSema clinical trial results The REDEFINE 1 trial enrolled adults with obesity or overweight (BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity) without type 2 diabetes